The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

by Anjana Bhardwaj, Harpreet Singh, Celestine Marie Trinidad, Constance T. Albarracin, Kelly K. Hunt, Isabelle Bedrosian
Published 2018-12-01

Erratum: Ju, Z., et al. Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That Is Globally Shared with Invasive Basal-Like Breas...

by Zhenlin Ju, Anjana Bhardwaj, Matthew D. Embury, Harpreet Singh, Preethi H. Gunaratne, Isabelle Bedrosian, Jing Wang
Published 2020-10-01

Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title:...

by Zhenlin Ju, Anjana Bhardwaj, Matthew D. Embury, Harpreet Singh, Preethi H. Gunaratne, Isabelle Bedrosian, Jing Wang
Published 2020-03-01

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.

by Anjana Bhardwaj, Nivetha Ganesan, Kazunoshin Tachibana, Kimal Rajapakshe, Constance T Albarracin, Preethi H Gunaratne, Cristian Coarfa, Isabelle Bedrosian
Published 2015-01-01

Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis.

by Anjana Bhardwaj, Daniel Rosen, Mei Liu, Yan Liu, Qiang Hao, Nivetha Ganesan, Carol J Etzel, Ashley Gullett, Constance T Albarracin, Isabelle Bedrosian
Published 2014-01-01

Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation

by Marco Napoli, Xiaobo Li, Hayley D. Ackerman, Avani A. Deshpande, Ivan Barannikov, Marlese A. Pisegna, Isabelle Bedrosian, Jürgen Mitsch, Philip Quinlan, Alastair Thompson, Kimal Rajapakshe, Cristian Coarfa, Preethi H. Gunaratne, Douglas C. Marchion, Anthony M. Magliocco, Kenneth Y. Tsai, Elsa R. Flores
Published 2020-10-01

Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis

by Amy C. Moreno, MD, Yan Heather Lin, PhD, Isabelle Bedrosian, MD, Yu Shen, PhD, Michael C. Stauder, MD, Benjamin D. Smith, MD, Thomas A. Buchholz, MD, Gildy V. Babiera, MD, Wendy A. Woodward, MD, PhD, Simona F. Shaitelman, MD, EdM
Published 2017-07-01

Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

by Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Published 2015-01-01

Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

by Priscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M Holder, Chandeshwar Sharma, Huiqin Chen, Kim-Anh Do, Emily Tarco, Mihai Gagea, Katherine A Naff, Aysegul Sahin, Asha S Multani, Dalliah M Black, Elizabeth A Mittendorf, Isabelle Bedrosian, Gordon B Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Published 2016-01-01